BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34181023)

  • 21. Immunosuppression is a Double-Edged Sword in COVID-19 Treatment: a Case Report of Rhino-Orbito-Cerebral Mucormycosis.
    Sedaghattalab M; Bagheri T; Doustimotlagh AH
    Clin Lab; 2022 Jul; 68(7):. PubMed ID: 35975535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First report of rhino-orbital-cerebral mucormycosis after COVID-19 infection in Bulgaria.
    Niyazi D; Toncheva B; Tonchev T; Dzhenkov D; Kalchev K; Stoeva T
    Future Microbiol; 2022 Sep; 17():1107-1113. PubMed ID: 35899489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective clinicopathological analysis of rhino-orbital mucormycosis in second wave of COVID-19.
    Thakur B; Ahuja S; Acharya S; Kaushik S
    Indian J Pathol Microbiol; 2023; 66(2):411-414. PubMed ID: 37077099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual hit - Magnetic resonance imaging in concomitant anterior and posterior ischemic optic neuropathy in a case of rhino-orbital mucormycosis and COVID-19.
    Kaushik KS; Acharya UV; Krupa L
    Indian J Ophthalmol; 2022 Jan; 70(1):300-301. PubMed ID: 34937262
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of medial orbital wall decompression in COVID-19-associated rhino-orbital mucormycosis management.
    Murthy R; Bagchi A; Gote YS
    Indian J Ophthalmol; 2021 Dec; 69(12):3795-3796. PubMed ID: 34827060
    [No Abstract]   [Full Text] [Related]  

  • 26. Spectrum of intracranial complications of rhino-orbito-cerebral mucormycosis - resurgence in the era of COVID-19 pandemic: a pictorial essay.
    Kaushik KS; Ananthasivan R; Acharya UV; Rawat S; Patil UD; Shankar B; Jose A
    Emerg Radiol; 2021 Dec; 28(6):1097-1106. PubMed ID: 34605991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19.
    Honavar SG
    Indian J Ophthalmol; 2021 Jun; 69(6):1361-1365. PubMed ID: 34011699
    [No Abstract]   [Full Text] [Related]  

  • 28. COVID-19 and orbital mucormycosis.
    Sarkar S; Gokhale T; Choudhury SS; Deb AK
    Indian J Ophthalmol; 2021 Apr; 69(4):1002-1004. PubMed ID: 33727483
    [No Abstract]   [Full Text] [Related]  

  • 29. "MuCovid-21" study: Mucormycosis at an Indian tertiary care centre during the COVID-19 pandemic.
    Kumar S; Choudhary R; Pandey VP
    J R Coll Physicians Edinb; 2021 Dec; 51(4):352-358. PubMed ID: 34882132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucormycosis in head and neck area - the emerging health problem in COVID-19 pandemic. The perspective of a dental practitioner.
    Pasternak M; Olszanecki R
    Folia Med Cracov; 2021; 61(2):117-127. PubMed ID: 34510169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatal rhino-orbito-cerebral mucormycosis infection associated with diabetic ketoacidosis post-COVID-19.
    Bonates P; João GAP; Cruz KS; Ferreira MS; Baía-da-Silva DC; Farias MEL; Brito-Sousa JD; Santana MF; Oliveira LA; Cortez ACA; Souza JVB; Lacerda MVG
    Rev Soc Bras Med Trop; 2021; 54():e03582021. PubMed ID: 34259759
    [No Abstract]   [Full Text] [Related]  

  • 32. Mucormycosis and Covid-19 : Risk Factors, Clinical Presentation and Outcome in a Tertiary Care Centre in North India.
    A GA; Ashraf H; HaiderMehdi HS
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comment on: Case series of central retinal artery occlusion in COVID-19-associated rhino-orbito-cerebral mucormycosis.
    Thomas PA
    Indian J Ophthalmol; 2024 Feb; 72(2):299-300. PubMed ID: 38273694
    [No Abstract]   [Full Text] [Related]  

  • 34. Initial and ongoing challenges with COVID-19-associated mucormycosis.
    Sikka K; Goel G; Sharma N; Thakar A
    Indian J Ophthalmol; 2021 Dec; 69(12):3391-3393. PubMed ID: 34826965
    [No Abstract]   [Full Text] [Related]  

  • 35. Covid-19 associated Mucormycosis: A case report.
    Shrestha O; Sharma Baral R
    J Nepal Health Res Counc; 2021 Sep; 19(2):414-416. PubMed ID: 34601541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunopathology of COVID-19 and its implications in the development of rhino-orbital-cerebral mucormycosis: a major review.
    Dave TV; Nair AG; Joseph J; Freitag SK
    Orbit; 2022 Dec; 41(6):670-679. PubMed ID: 35856238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver cirrhosis and rhino-orbital mucormycosis, a possible but rare association: description of a clinical case and literature review.
    Pellicelli AM; D'Ambrosio C; Villani R; Cerasari G; Ialongo P; Cortese A; Grillo LR; Soccorsi F
    Braz J Infect Dis; 2009 Aug; 13(4):314-6. PubMed ID: 20231998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pediatric rhino-orbital mucormycosis. First peruvian case in times of the COVID-19 pandemic].
    Meregildo-Rodriguez ED; Espino-Saavedra WG
    Rev Peru Med Exp Salud Publica; 2021; 38(3):472-473. PubMed ID: 34932752
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute Invasive Fungal Rhinosinusitis and Coronavirus Disease 2019.
    Abdel-Aziz M; Azab N
    J Craniofac Surg; 2021 Nov-Dec 01; 32(8):e827-e830. PubMed ID: 34560756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhino-orbital-cerebral mucormycosis: fungal epidemic in a viral pandemic.
    Chouhan M; Solanki B; Shakrawal N
    J Laryngol Otol; 2021 Nov; 135(11):981-986. PubMed ID: 34470691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.